SCHEMBL7729473

SCHEMBL7729473

CN(CC(=O)N[C@@H]1C[C@@H](C(=O)O)N(C(=O)OC(C)(C)C)C1)C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 3/20 0.36
BTK Q06187 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MMP2 P08253 1/20 0.34
ANPEP P15144 1/20 0.34
HSD17B10 Q99714 1/20 0.33
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
NR1H2 P55055 1/20 0.32
TLR2 O60603 1/20 0.32
TLR1 Q15399 1/20 0.32
UCHL1 P09936 1/20 0.32
HTRA1 Q92743 1/20 0.32
ACE P12821 2/20 0.31
CTSL P07711 1/20 0.31
CTSB P07858 1/20 0.31
CTSS P25774 1/20 0.31
CTSK P43235 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7729472 1.00 AGTR2 (0.36) AGTR2BTKSMN1; SMN2MMP2ANPEP
SCHEMBL7733245 0.90 MMP2 (0.38) MMP2ANPEPCYP1A2POLBCYP3A4
SCHEMBL7733241 0.90 MMP2 (0.38) MMP2ANPEPCYP1A2POLBCYP3A4
SCHEMBL7727152 0.90 AGTR2 (0.38) AGTR2BTKSMN1; SMN2MMP2ANPEP
SCHEMBL7727155 0.90 AGTR2 (0.38) AGTR2BTKSMN1; SMN2MMP2ANPEP
SCHEMBL7727788 0.82 BTK (0.44) AGTR2BTKMMP2ANPEPTLR2
SCHEMBL7727791 0.82 BTK (0.44) AGTR2BTKMMP2ANPEPTLR2
SCHEMBL10594861 0.80 BTK (0.41) AGTR2BTKSMN1; SMN2MMP2ANPEP
SCHEMBL10594866 0.80 BTK (0.41) AGTR2BTKSMN1; SMN2MMP2ANPEP
SCHEMBL7727967 0.79 BTK (0.40) AGTR2BTKSMN1; SMN2MMP2ANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed